Amount Raised
$500 Million
Round Type
Post-IPO Equity
CambridgeBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalInvestors
Description
On August 19, 2026, Amylyx Pharmaceuticals, Inc. completed an underwriting agreement for the issuance of 14,090,000 shares of common stock at $35.50 per share. The company also granted underwriters an option to purchase additional shares. This funding will support the company’s ongoing development of therapeutics for neurodegenerative diseases.
Quick answer
Amylyx Pharmaceuticals raised $500 Million in a Post-IPO Equity round, dated August 20, 2026. Investors: LifeSci Capital LLC, Guggenheim Securities, LLC, Morgan Stanley & Co. LLC and Leerink Partners LLC. Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- How much did Amylyx Pharmaceuticals raise?
- Amylyx Pharmaceuticals raised $500 Million in a Post-IPO Equity round on August 20, 2026.
- Who invested in Amylyx Pharmaceuticals?
- LifeSci Capital LLC, Guggenheim Securities, LLC, Morgan Stanley & Co. LLC and Leerink Partners LLC are named as investors in this round.
- What does Amylyx Pharmaceuticals do?
- Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments.
- Where is Amylyx Pharmaceuticals based and how big is it?
- Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States. Fundz records about 384 employees.
- Who are the decision-makers at Amylyx Pharmaceuticals?
- Fundz holds 1 contact at Amylyx Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Amylyx Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $5M on August 10, 2026.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
- Breye Therapeutics raised $77M (Series A) on September 29, 2026.
- Lisata Therapeutics raised $352M (Series C) on September 17, 2026.
- Matisse Pharmaceuticals B.V raised $16M (Series A) on September 17, 2026.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
Who to call at Amylyx Pharmaceuticals, and when
A new round usually means Amylyx Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amylyx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amylyx Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amylyx Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amylyx Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Amylyx Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.